297 related articles for article (PubMed ID: 31578435)
1. Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation.
Ricobaraza A; Mora-Jimenez L; Puerta E; Sanchez-Carpintero R; Mingorance A; Artieda J; Nicolas MJ; Besne G; Bunuales M; Gonzalez-Aparicio M; Sola-Sevilla N; Valencia M; Hernandez-Alcoceba R
Sci Rep; 2019 Oct; 9(1):14172. PubMed ID: 31578435
[TBL] [Abstract][Full Text] [Related]
2. Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome.
Alonso C; Satta V; Díez-Gutiérrez P; Fernández-Ruiz J; Sagredo O
Neuropharmacology; 2022 Mar; 205():108914. PubMed ID: 34875285
[TBL] [Abstract][Full Text] [Related]
3. Convulsive seizures and some behavioral comorbidities are uncoupled in the Scn1a
Fadila S; Quinn S; Turchetti Maia A; Yakubovich D; Ovadia M; Anderson KL; Giladi M; Rubinstein M
Epilepsia; 2020 Oct; 61(10):2289-2300. PubMed ID: 32865826
[TBL] [Abstract][Full Text] [Related]
4. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
[TBL] [Abstract][Full Text] [Related]
5. Adolescent behavioral abnormalities in a Scn1a
Bahceci D; Anderson LL; Occelli Hanbury Brown CV; Zhou C; Arnold JC
Epilepsy Behav; 2020 Feb; 103(Pt A):106842. PubMed ID: 31870807
[TBL] [Abstract][Full Text] [Related]
6. Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program.
Pernici CD; Mensah JA; Dahle EJ; Johnson KJ; Handy L; Buxton L; Smith MD; West PJ; Metcalf CS; Wilcox KS
Epilepsia; 2021 Jul; 62(7):1665-1676. PubMed ID: 34002394
[TBL] [Abstract][Full Text] [Related]
7. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
Niibori Y; Lee SJ; Minassian BA; Hampson DR
Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
[TBL] [Abstract][Full Text] [Related]
8. Behavioral phenotyping of young Scn1a haploinsufficient mice.
Reiber M; Miljanovic N; Schönhoff K; Palme R; Potschka H
Epilepsy Behav; 2022 Nov; 136():108903. PubMed ID: 36240579
[TBL] [Abstract][Full Text] [Related]
9. From focal epilepsy to Dravet syndrome--Heterogeneity of the phenotype due to SCN1A mutations of the p.Arg1596 amino acid residue in the Nav1.1 subunit.
Hoffman-Zacharska D; Szczepanik E; Terczynska I; Goszczanska-Ciuchta A; Zalewska-Miszkurka Z; Tataj R; Bal J
Neurol Neurochir Pol; 2015; 49(4):258-66. PubMed ID: 26188943
[TBL] [Abstract][Full Text] [Related]
10. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
Miller AR; Hawkins NA; McCollom CE; Kearney JA
Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
[TBL] [Abstract][Full Text] [Related]
11. Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments.
Satta V; Alonso C; Díez P; Martín-Suárez S; Rubio M; Encinas JM; Fernández-Ruiz J; Sagredo O
Front Mol Neurosci; 2020; 13():602801. PubMed ID: 33584198
[TBL] [Abstract][Full Text] [Related]
12. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW
Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421
[TBL] [Abstract][Full Text] [Related]
13. Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome.
Wengert ER; Wagley PK; Strohm SM; Reza N; Wenker IC; Gaykema RP; Christiansen A; Liau G; Patel MK
Brain Res; 2022 Jan; 1775():147743. PubMed ID: 34843701
[TBL] [Abstract][Full Text] [Related]
14. Disordered breathing in a mouse model of Dravet syndrome.
Kuo FS; Cleary CM; LoTurco JJ; Chen X; Mulkey DK
Elife; 2019 Apr; 8():. PubMed ID: 31025941
[TBL] [Abstract][Full Text] [Related]
15. [
Haginoya K; Togashi N; Kaneta T; Hino-Fukuyo N; Ishitobi M; Kakisaka Y; Uematsu M; Inui T; Okubo Y; Sato R; Miyabayashi T; Arai A; Ogiwara I; Mazaki E; Yamakawa K; Iinuma K; Kure S
Epilepsy Res; 2018 Nov; 147():9-14. PubMed ID: 30176532
[TBL] [Abstract][Full Text] [Related]
16. Atypical myelinogenesis and reduced axon caliber in the Scn1a variant model of Dravet syndrome: An electron microscopy pilot study of the developing and mature mouse corpus callosum.
Richards K; Jancovski N; Hanssen E; Connelly A; Petrou S
Brain Res; 2021 Jan; 1751():147157. PubMed ID: 33069731
[TBL] [Abstract][Full Text] [Related]
17. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.
Cheah CS; Lundstrom BN; Catterall WA; Oakley JC
J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705
[TBL] [Abstract][Full Text] [Related]
18. A novel rat model of Dravet syndrome recapitulates clinical hallmarks.
Li M; Yang L; Qian W; Ray S; Lu Z; Liu T; Zou YY; Naumann RK; Wang H
Neurobiol Dis; 2023 Aug; 184():106193. PubMed ID: 37295561
[TBL] [Abstract][Full Text] [Related]
19. Mouse with Nav1.1 haploinsufficiency, a model for Dravet syndrome, exhibits lowered sociability and learning impairment.
Ito S; Ogiwara I; Yamada K; Miyamoto H; Hensch TK; Osawa M; Yamakawa K
Neurobiol Dis; 2013 Jan; 49():29-40. PubMed ID: 22986304
[TBL] [Abstract][Full Text] [Related]
20. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
